Clinical Trial Update: Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating single-agent and combined inhibition after allogeneic stem cell transplant in patients with acute myeloid leukemia and myelody…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Acute Myeloid Leukemia and Myelodysplastic Syndrome | Phase 1 | Status: TERMINATED